Israeli med device startup Laminate Medical Technologies has raised $8 million Series B financing round to support its VasQ blood vessel support device. The company’s VasQ device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. The VasQ regulates flow by “constraining and shaping optimal […]
Vascular
Study finds higher complication risk with Cardinal Health’s Mynx vascular closure device
A study published last week in The New England Journal of Medicine concluded that patients treated with Cardinal Health (NYSE:CAH)’s Mynx vascular closure device are at higher risk for vascular complications compared to patients that received alternative vascular closure devices. The data also suggested that patients who received the Mynx device were at greater risk for access site bleeding […]
Avinger touts 2-year Pantheris study data
Avinger (NSDQ:AVGR) today released 2-year interim data from the pivotal Vision trial of its Pantheris system, touting high rates of freedom from target lesion revascularization. The study aimed to analyze the effectiveness of the Pantheris during directional atherectomy procedures, the Redwood City, Calif.-based company said. The Pantheris device is designed to be used to identify vessel lumen […]
Endologix wins CE Mark reinstatement for AFX, AFX2, touts 3-year post market Ovation study
Endologix (NSDQ:ELGX) said today it received notice that the CE Mark approval for its AFX and AFX2 endovascular abdominal aortic aneurysm systems has been reinstated, effective immediately, after being put on hold in early December. The Irvine, Calif.-based company also released 3-year post-market registry data on its Ovation system, designed to treat abdominal aortic aneurysms, touting a […]
PQ Bypass study meets safety, efficacy endpoints
PQ Bypass said yesterday that its Detour I trial met its primary safety and efficacy endpoints. The company’s trial is evaluating its fully percutaneous bypass treatment for patients with complex superficial femoral artery occlusions. The Sunnyvale, Calif.-based company’s procedure is less invasive compared to traditional treatment options to revascularize arterial blockages in the leg. PQ […]
How Howard Root guided Vascular Solutions to a $1B buyout – and beat federal prosecutors
Fresh from a huge legal win over the U.S. Justice Dept., Howard Root guided Vascular Solutions to a $1 billion buyout. Here’s what he learned about leadership along the way. It’s been a banner year in many ways for Vascular Solutions. Apart from top-line growth of some 17%, the company was named to the Forbes […]
Medtronic touts In.Pact Admiral drug-coated balloon data
Medtronic (NYSE:MDT) touted data for its In.Pact Admiral drug-coated balloon in patients with peripheral arterial disease. The company presented outcomes from its In.Pact Global study patient cohorts in Asia and Belgium, concluding that its DCB demonstrated consistent outcomes across patient populations. More than 96% of the 114-patient study group in Asia achieved positive outcomes, which […]
Spectranetics touts high primary patency, low CD-TLR for Stellarex DCB data in complex cases
Spectranetics (NSDQ:SPNC) today released 12-month data from the Illumenate global study of its Stellarex drug-coated balloon in treating peripheral artery disease in superficial femoral and popliteal arteries, touting a high rate of primary patency in patients with complex lesions. The 371-patient Illumenate global study included lesions which were “highly complex,” according to the Colorado Springs, Colo.-based company, and […]
Medtronic wins CE Mark for 6F HawkOne PAD atherectomy system
Medtronic (NYSE:MDT) said today it won CE Mark approval in the European Union for a 6 French version of its HawkOne directional atherectomy device designed for treating peripheral artery disease. The Fridley, Minn.-based company’s device is designed as a treatment for PAD which can operate both above and below the knee. “Directional atherectomy is an established […]
CardioFocus launches next-gen HeartLight Exalibur balloon trial
CardioFocus said today it launched a clinical trial of its next-generation HeartLight Excalibur balloon device designed for pulmonary vein isolation procedures. The Marlborough, Mass.-based company said the next-gen device incorporates the balloon design from its HeartLight endoscopic ablation system alongside a new advanced feature set intended to improve speed and the magnitude of target tissue contact during […]
Intact Vascular wins CE Mark for Tack blood vessel repair device
Intact Vascular said today that it won CE Mark approval in the European Union for its Tack endovascular system to repair arterial dissections after percutaneous transluminal angioplasty below the knee. The indication extends the system’s use in the EU to the tibial arteries between the knee and the ankle. The Tack implant can be used in arteries ranging from […]